CTOs on the Move

VisCardia

www.viscardia.com

 
VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.viscardia.com
  • Creekside Corporate Park 8770 SW Nimbus Ave
    Beaverton, OR USA 97008
  • Phone: 503.431.3800

Executives

Name Title Contact Details

Funding

VisCardia raised $12.5M on 02/01/2017

Similar Companies

Barnett and Ramel Optical

Barnett and Ramel Optical is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dedham Medical Assoc

Dedham Medical Assoc is a Dedham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ESA Biosciences

ESA Biosciences is a Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

heartstent

heartstent is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.